COVID-19 : Up to 82% critically ill patients had low Vitamin C values
© 2021. The Author(s)..
There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Nutrition journal - 20(2021), 1 vom: 09. Juli, Seite 66 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tomasa-Irriguible, Teresa Maria [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ARDS |
|---|
| Anmerkungen: |
Date Completed 26.07.2021 Date Revised 12.08.2022 published: Electronic CommentIn: Nutr J. 2022 Jul 29;21(1):48. - PMID 35906596 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12937-021-00727-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327896523 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327896523 | ||
| 003 | DE-627 | ||
| 005 | 20231225201808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12937-021-00727-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327896523 | ||
| 035 | |a (NLM)34243781 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tomasa-Irriguible, Teresa Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 |b Up to 82% critically ill patients had low Vitamin C values |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.07.2021 | ||
| 500 | |a Date Revised 12.08.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentIn: Nutr J. 2022 Jul 29;21(1):48. - PMID 35906596 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a ARDS | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Critically ill patient | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a ICU | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Vitamin C | |
| 650 | 7 | |a Vitamins |2 NLM | |
| 650 | 7 | |a Ascorbic Acid |2 NLM | |
| 650 | 7 | |a PQ6CK8PD0R |2 NLM | |
| 700 | 1 | |a Bielsa-Berrocal, Lara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nutrition journal |d 2002 |g 20(2021), 1 vom: 09. Juli, Seite 66 |w (DE-627)NLM123191157 |x 1475-2891 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:1 |g day:09 |g month:07 |g pages:66 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12937-021-00727-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 1 |b 09 |c 07 |h 66 | ||